We also observed that lung, blood, brain and skin cancers have reduced CDS1 levels compared with their lineages of origin (Extended Data Fig. 1g), suggesting that these cancers may suppress transcription of CDS1 during cancer development. This evidence concerns the gene CDS1 and skin cancer.